Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc covers the month of March 2026, with the report dated March 30, 2026. Haleon is a consumer health company focused on everyday health, with a portfolio spanning Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. The filing specifically details transactions in the company's own shares under a buyback programme announced on March 12, 2026.
Key Financial Metrics and Share Transactions
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity. Between March 23 and March 27, 2026, Haleon purchased a total of 8,939,706 ordinary shares for cancellation. The transactions occurred across three trading venues: London Stock Exchange (LSE), CBOE (UK)/BXE, and CBOE (UK)/CXE.
| Date | Total Shares Purchased | Price Range (p) | Weighted Avg Price (p) |
|---|---|---|---|
| March 23, 2026 | 2,199,999 | 366.10 - 373.00 | 369.34 |
| March 24, 2026 | 2,747,110 | 353.70 - 367.50 | 360.72 |
| March 25, 2026 | 1,599,999 | 358.00 - 365.00 | 360.71 |
| March 26, 2026 | 1,093,537 | 361.30 - 365.70 | 363.86 |
| March 27, 2026 | 1,299,059 | 361.20 - 367.20 | 364.64 |
Following these transactions, the company's registered share capital stands at 8,932,831,335 ordinary shares of £0.01 each. Of these, 12,548,735 are held as treasury shares, leaving 8,920,282,600 ordinary shares with voting rights.
Material Changes and Outlook
The filing does not report material changes to financial performance, guidance, or outlook compared to prior periods. The primary change is the reduction in the number of outstanding shares due to the buyback programme. Management commentary is limited to the execution of the share repurchase and the update on share capital structure. No specific risks, contingencies, or unusual items beyond the standard share transaction disclosure are mentioned in this document.
Investor Verification Checklist
- Verify the total number of shares purchased (8,939,706) and the aggregate cost against the company's cash position in the most recent quarterly report.
- Confirm the updated number of voting shares (8,920,282,600) for calculating ownership thresholds under FCA Disclosure Guidance and Transparency Rules.
- Review the full breakdown of individual trades available via the provided RNS link to ensure compliance with Market Abuse Regulation Article 5(1)(b).
- Check the company's website (www.haleon.com/investors) for the detailed trade breakdown and any subsequent updates to the buyback programme.